Survival analysis showed that uHCC patients with ECOG-PS 2, Child-Pugh class B, BCLC stage C, portal vein tumor thrombus, tumor size ≥10 cm, HBV positive, AFP ≥ 400, and NLP ≥ 2.195 had a significantly shorter OS, as exhibited in Figures 3A–H. This evidence concerns the gene AFP and neoplasm.